Journal article icon

Journal article

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.

Abstract:

BACKGROUND: Macroadenomas causing acromegaly are cured surgically in only around 50% of patients. Primary medical treatment with somatostatin analogues has been suggested to be a means of treating patients with a potentially poor surgical outcome. Previous retrospective studies have also suggested that surgical debulking of pituitary tumours causing acromegaly improves control by somatostatin analogues. No prospective study using lanreotide has been carried out thus far to assess whether this...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, OCDEM
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Surgical Sciences
Role:
Author
Expand authors...
Journal:
Clinical endocrinology
Volume:
68
Issue:
6
Pages:
970-975
Publication date:
2008-06-05
DOI:
EISSN:
1365-2265
ISSN:
0300-0664
URN:
uuid:176562a9-db5a-4e36-bcef-599a01001086
Source identifiers:
8706
Local pid:
pubs:8706

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP